USE OF C9ORF72 -MEDIATED GENES FOR DIAGNOSIS AND TREATMENT OF NEURONAL DISEASES Application WO-2023055657-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2023
Compositions for modulating C9ORF72 expression Grant US-11339393-B2 United States of America 24 May 2022
Compounds and methods for modulating C90RF72 Grant US-11260073-B2 United States of America 01 Mar 2022
Compositions for modulating expression of C9ORF72 antisense transcript Grant US-11193128-B2 United States of America 07 Dec 2021